Patchology

Patchology is an American skincare brand based in Boston, Massachusetts, known for fast-acting eye patches and sheet masks. It was launched in 2014 by Chris Hobson [1][2], growing out of a medical-field venture that had developed transdermal patches for drug delivery. The brand is the founding label of Rare Beauty Brands, a multi-brand platform Hobson leads as chief executive [3]. It remains active, with prestige distribution across the United States, the United Kingdom, continental Europe and Australia.

⚑ Thinner sourcing. The article relies largely on the brand's own statements (T2–T3). Glowpedia is seeking independent sources.

According to the company, the story began in the medical field, where its founders worked on transdermal patches designed to deliver treatments through the upper layers of skin. That experience in ingredient delivery was redirected toward consumer skincare, and the Patchology beauty brand launched in 2014. Founder Chris Hobson had begun his career at Procter & Gamble before moving into entrepreneurship. The trade publication BeautyMatter describes the company behind Patchology as an early developer of advanced transdermal patch technologies, holding several patents in the space before applying them to beauty [2].

Patchology sits within Rare Beauty Brands, a company built on Patchology's own infrastructure; Patchology is the platform's founding brand rather than an outside acquisition, and Hobson serves as president and chief executive of both [3]. The stated strategy is to acquire bootstrapped indie brands with clear points of differentiation and grow them using Patchology's operational experience. Under that model, Rare Beauty Brands purchased the skincare and body-care label Plant Apothecary [3], and in October 2025 acquired Kate Somerville from Unilever, including its Melrose Place clinic in Los Angeles [5].

Patchology frames skincare as a form of self-care aimed at busy people, with products designed to deliver visible, refreshed-looking results in about five minutes. "Self-care isn't selfish," the brand states on its About page, adding that everything it makes is built around the customer's available moment, "whether you have 5 or 50 minutes." Its mission statement is "beauty at the speed of you." The company positions itself in the prestige tier and identifies busy millennial women as its core audience, while noting appeal among Gen X and Gen Z shoppers.

The brand's range centres on eye patches, sheet masks and face masks. Its flagship product is the FlashPatch Rejuvenating Eye Gels, an under-eye treatment formulated with peptides, hyaluronic acid and caffeine. Other recurring products include the Serve Chilled On Ice Eye Gels, the FlashPatch Restoring Night Eye Gels, the Rosé Eye Gels and the All Golden eye mask.

Patchology attributes its signature five-minute results to a proprietary delivery technology and to the transdermal-patch heritage behind the company. The brand describes the technology as "Hydrosurge5" on its official About page [1], though a founder interview refers to it as "HydraSurge" [3]. The company says its eye patches and sheet masks are the only ones to deliver results in as little as five minutes [2]. Products are sold through a multi-channel network of prestige and specialty retailers, including Ulta, Nordstrom, Bluemercury, SpaceNK, Mecca and, in Europe, Sephora. In 2023 the brand introduced its "iced" chilled eye gels and face masks, alongside RareCycle recycling sachets presented as a sustainability initiative.

Patchology products have been featured by beauty editors and in awards coverage. Its All Golden eye mask was named Best Eye Mask in the 2025 Shape Skin Awards [6]. Editors at Allure named the Serve Chilled On Ice Eye Gels a top pick for firming, the Rosé Eye Gels appeared in a Byrdie skincare gift guide, and the brand's eye gels have been listed among Harper's Bazaar's picks in the category.

The brand is active. Its most recent visible corporate activity is the October 2025 acquisition of Kate Somerville by its parent, Rare Beauty Brands, which points to continued expansion of the wider platform [5]. Distribution remains concentrated across the United States, the United Kingdom, Europe and Australia.